Osiris Therapeutics: Expecting Better In 2018

12/8/17

https://static.seekingalpha.com/uploads/2017/11/26/19169511-1511711788750797.png

What Is Osiris Therapeutics?

Osiris Therapeutics (NASDAQ:OSIR) spun out of Case Western Reserve University in 1992 to leverage stem cell technology discovered by Dr. Arnold Caplan and his team of researchers.

By May 2012, Osiris received marketing clearance from Health Canada for the world's first approved stem cell drug (Prochymal).

In August 2013, we learned that Grafix demonstrated overwhelming efficacy in a landmark stem cell study for the treatment of diabetic foot ulcers. Grafix closes 3 times as many wounds as standard of care - the largest relative improvement ever reported in a multi-center, randomized, controlled clinical trial for DFU.

READ FULL ARTICLE HERE

It's on us. Share your news here.

Submit your stories and articles to citybizlist today.

Baltimore Business Spotlight

Feature Your Business Here

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect